StonvexLoading…
StonvexStonvexStonvexCore line items from NRG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $7.34B | $10.14B | $30.35B | $22.66B | $15.16B |
Operating Income | Not available | $328.00M | $1.84B | $1.55B | $1.13B |
Net Income | Not available | $125.00M | $864.00M | $798.00M | $646.00M |
EPS (Diluted) | $1.95 | $0.52 | $4.01 | $3.72 | $3.01 |
Total Assets | Not available | $40.05B | $29.14B | $23.97B | $24.09B |
Total Liabilities | Not available | $35.18B | $27.46B | $22.00B | $21.80B |
Cash & Equivalents | Not available | $178.00M | $4.71B | $732.00M | $180.00M |
Free Cash Flow OCF − CapEx | Not available | $-486.00M | $766.00M | $941.00M | $711.00M |
Shares Outstanding | Not available | 212.76M | 190.38M | 192.26M | 194.63M |